The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Pneumonia tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Table of Contents

I. Introduction

II. PNEUMONIA Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

III. France: Test Volume and Diagnostics Sales Forecast by Market Segment

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Test Volume and Diagnostics Sales Forecast by
Market Segment

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

List of Tables

Major Companies Developing or Marketing Pneumonia Tests
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Pneumonia Testing Market Diagnostics Sales by Major Supplier
Italy Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Pneumonia Testing Market Diagnostics Sales by Major Supplier
Spain Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier